Trikafta (elexacaftor / tezacaftor / ivacaftor)

Product Name:

Trikafta (elexacaftor / tezacaftor / ivacaftor)

Categories: Genetic & Advanced Therapies, Pediatric Genetics, Rare Diseases

Discover Savings on Your Medication Access

Trusted concierge service, secure process, and real savings for patients in the U.S.

Table of Contents

Trikafta
(elexacaftor / tezacaftor / ivacaftor)

Product Category

Cystic Fibrosis Therapy – CFTR Modulator

Brand Name

Trikafta

Generic Name or Biosimilar

No

Active Ingredient

Elexacaftor, Tezacaftor, Ivacaftor

Prescription Status

Prescription-only

Targeted Conditions

Trikafta is indicated for the treatment of cystic fibrosis (CF) in patients aged 2 years and older who have at least one F508del mutation in the CFTR gene, which is the most common cause of CF.

Off-Label Usage

While Trikafta is strictly approved for cystic fibrosis with F508del mutations, off-label interest includes:

  • Investigational use in rare CFTR mutations not included in the original approval
  • Research into earlier intervention in pediatric CF patients younger than 2 years (currently under study)
  • Use in combination with other gene therapy approaches (investigational only)

All off-label uses should be guided by CF specialists and conducted under research protocols.

Drug Classification Overview

Trikafta is a CFTR modulator, a class of medications that improve the function of the defective CFTR protein caused by gene mutations.

It is a combination of:

  • Elexacaftor and Tezacaftor: CFTR correctors that help the protein fold correctly
  • Ivacaftor: A CFTR potentiator that increases the activity of the protein at the cell surface

This triple combination significantly improves lung function and other symptoms in eligible CF patients.

Manufacturer in the USA, Mexico, and Canada

USA: Vertex Pharmaceuticals
Mexico: Not commercially available (access may be coordinated under special conditions)
Canada: Vertex Pharmaceuticals (Canada) Inc.

Available Strengths and Dosage Forms – United States, Mexico, and Canada

Country Comparison – United States vs Mexico and Canada

  • Formulation: Equivalent active ingredients
  • Availability: Full commercial access in the U.S. and Canada; limited access in Mexico
  • Regulation: FDA (U.S.), Health Canada, COFEPRIS (Mexico – under import or special program)
  • Packaging and Language: Varies according to regional labeling requirements

Average Retail Price (Monthly Treatment) USA vs Mexico vs Canada

Mexico: Approximate savings of 35–55%
Canada: Approximate savings of 30–50%

These are general estimates and may vary depending on product availability, controlled status, import restrictions, cold chain requirements, and demand fluctuations. Trikafta is often subject to special approval or direct coordination with manufacturers.

Where to Buy USA

Costco, CVS, Walgreens, Rite Aid, Walmart, Kroger, Albertsons, Sam’s Club, Publix, Target (via CVS Pharmacy), and Online mail-order specialty care pharmacies.

Due to its specialty status and high cost, Trikafta may require coordination through a specialty pharmacy and insurance pre-authorization.

Storage Requirements

  • Store Trikafta at room temperature between 20°C to 25°C (68°F to 77°F).
  • Protect from moisture.
  • Refrigeration is not required, but packaging must be kept sealed until use.

Shipping from Canada

This medication is accessed through fully licensed Canadian pharmacies regulated by Health Canada. All pharmacies included in the MedicalMex network undergo a rigorous review and verification process to ensure compliance with national standards, patient safety, and medication authenticity.

MedicalMex facilitates:

  • Prescription verification and fulfillment coordination
  • Secure, compliant medication logistics
  • Access to licensed Canadian pharmacists
  • Access to our network of certified physicians if a Telehealth consultation is needed
  • Case management, payment handling, and personalized boutique-level support
  • Cold chain shipping with next-generation temperature-monitored coolers, when required
  • Refill tracking and patient adherence programs

You are working directly with MedicalMex Inc., a U.S.-based company that helps eligible patients safely access affordable medications from Canada — with compliance and full-service concierge support at every step.

Buying from Mexico

This medication is also available through certified pharmacies in Mexico regulated by COFEPRIS (Mexico’s national health authority). All partners in the MedicalMex network must pass a rigorous review and certification process before being approved for patient access.

MedicalMex facilitates:

  • Transportation support to our affiliate clinic in Tijuana, Mexico
  • Prescription handling through licensed physicians within our certified network
  • Access to our network of accredited physicians if a Telehealth consultation is needed
  • Travel coordination, including flights and/or hotel reservations when required
  • Travel insurance
  • Cold chain shipping with advanced temperature-monitored coolers, when applicable
  • Personalized, boutique-level service
  • Refill tracking and patient adherence support

You are working directly with MedicalMex Inc., a U.S.-based company that manages every detail — from medical and travel logistics to prescription compliance — providing secure, affordable access to life-saving medications from Mexico.

Key Benefits

  • Major improvement in lung function (FEV1)
  • Reduction in pulmonary exacerbations
  • Improved quality of life and nutritional outcomes
  • Targets the underlying cause of CF for patients with the F508del mutation
  • Approved for patients as young as 2 years old (as of latest FDA update)

Side Effects

Common Side Effects:

  • Headache
  • Diarrhea
  • Upper respiratory tract infections
  • Stomach pain
  • Rash

Serious Side Effects:

  • Elevated liver enzymes
  • Cataracts in pediatric patients
  • Drug interactions with CYP3A substrates
  • Hypersensitivity reactions

Warnings and Precautions

  • Monitor liver enzymes before and during treatment
  • Use caution in patients with advanced liver disease
  • May cause drug interactions with CYP3A inducers or inhibitors
  • Not recommended during pregnancy unless clearly needed
  • Pediatric patients require monitoring for eye health

Alternative Medications (by Indication)

  • Kalydeco (ivacaftor) – For patients with other gating mutations
  • Symdeko (tezacaftor/ivacaftor)
  • Orkambi (lumacaftor/ivacaftor) – For patients homozygous for F508del
  • Inhaled antibiotics (as adjunct, not alternative)
  • Bronchodilators and mucolytics – Symptomatic support

Medication FAQs

Trikafta is used to treat cystic fibrosis in patients 2 years and older who have at least one F508del mutation in the CFTR gene. It improves lung function and reduces complications associated with CF.

No, but it targets the underlying protein defect in many patients and significantly improves symptoms and quality of life.

It’s taken orally in two doses: a morning dose (2 tablets) and an evening dose (1 tablet). All doses must be taken with food that contains fat.

Yes, a valid prescription from a licensed physician is required to purchase Trikafta through any pharmacy, including those accessed via MedicalMex.

Yes. MedicalMex facilitates safe and compliant access to Trikafta from fully licensed pharmacies in Canada and Mexico, under prescription and full coordination.

No, it is stored at room temperature. However, secure handling and protection from moisture are important.

We provide a full-service, concierge-level coordination system. This includes access to verified pharmacies, prescription management, case support, physician consultation when needed, and cold chain compliance.

Follow the instructions from your doctor. Typically, if a dose is missed, take it as soon as possible unless it’s close to the next dose.

Yes, it is currently approved for patients aged 2 and older with at least one F508del mutation.

Other CFTR modulators like Orkambi, Symdeko, and Kalydeco may be prescribed depending on your specific genetic mutation.